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Abstract 14 
The objective of this study is to propose a novel optical compressibility parameter for porous 15 
pharmaceutical tablets. This parameter is defined with the aid of the effective refractive index 16 
of a tablet that is obtained from non-destructive and contactless terahertz (THz) time-delay 17 
transmission measurement. The optical compressibility parameter of two training sets of 18 
pharmaceutical tablets with a priori known porosity and mass fraction of an active 19 
pharmaceutical ingredient (API) was investigated. Both pharmaceutical sets were compressed 20 
with microcrystalline cellulose (MCC) and the API Indomethacin. The optical compressibility 21 
clearly correlates with the bulk modulus determined by mercury porosimetry and the recently 22 
proposed terahertz lumped structural parameter calculated from terahertz measurements. This 23 
lumped structural parameter can be used to analyse the pattern of arrangement of excipient and 24 
API particles in porous pharmaceutical tablets. Therefore, we propose that the optical 25 
compressibility can serve as a quality parameter of a pharmaceutical tablet corresponding with 26 
the bulk modulus of the porous tablet, which is related to structural arrangement of the powder 27 
particles and the bulk modulus of a porous tablet. 28 
 29 
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 37 
Introduction  38 
For pharmaceutical applications tablets are the accepted and most widely used dosage form 39 
due to their being cost effective to manufacture, having relative ease of large scale of 40 
production, resulting product stability, related to the availability of reliable manufacture 41 
processes, and ability to provide correct reproducible dosage of drug from tablet to tablet and 42 
the convenience for patients [1, 2]. Critical quality attributes, such as disintegration time or 43 
amount of API dissolved after a certain time, are linked to their physical, mechanical, chemical, 44 
biological and also optical properties. During formation of a tablet, the mixture of drug and 45 
excipient particles is compacted, usually directly or following a granulation step, into a stable 46 
porous solid. 47 
Historically, mechanical properties have played an important role in order to assess the 48 
functionality of a pharmaceutical tablet following the compaction step. Indentation, elasticity, 49 
tensile strength, brittle fracture index, bonding index, strain index, viscoelasticity, 50 
compressibility, compatibility, and tabletability are among the various mechanical properties 51 
of a tablet that have been explored in depth [3 - 8]. The mechanical properties of pharmaceutical 52 
tablets can be described by the relationship between the applied force during the compression 53 
and the resulting plastic deformation, and inter-particle bonding within the tablet [9]. These 54 
dictate the behaviour of pharmaceutical powder mixtures both during and after compaction. 55 
Stress and strain are the basic mechanical properties to describe the relationship between 56 
compressive pressure and the resulting deformation [8]. Compressibility (solid fraction as a 57 
function of compaction pressure) and compactibility (tensile strength in relation to solid 58 
fraction) [10] are terms commonly used to describe the densification and reduction in volume 59 
of a powder bed by the application of pressure alone, and both properties are considered to be 60 
the major parameters contributing to tabletability, defined as the dependence of tensile strength 61 
on compaction pressure [11]. In this study, we propose to establish an optical parameter that is 62 
related to the mechanical properties, such as the bulk modulus of pharmaceutical tablets. This 63 
topic of high importance in pharmaceutical sciences (see, for example, reference to strain [4 - 64 
8, 10] and compressibility [12 ± 18]).  In this study, the emphasis is on the research of the 65 
development of non-contact sensing and data analysis methods to quantify structural and 66 
mechanical properties of pharmaceutical tablets using terahertz (THz) time-delay measurement 67 
techniques [19]. 68 
Recently, we have introduced a novel structural parameter (S), which describes the pattern of 69 
arrangement of different constituents in porous pharmaceutical tablets [20]. By pattern 70 
arrangement we mean the arrangement of drug and excipient constituting the skeletal-pore 71 
elements (solid phase) in series, parallel or a mix of both patterns. This structural parameter is 72 
assumed to play an important role both in the compressibility of a tablet, and in the description 73 
of the ingress and permeation of liquids in pharmaceutical tablets. In addition to developing 74 
the optical compressibility parameter, we consider in more detail the structural parameter S in 75 
respect to the explicit dependence of S on a range of various tablet properties, and analyse the 76 
correlation of the optical compressibility parameter with S.  77 
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This study continues our work to retrieve physical parameters, which directly affect critical 78 
quality attributes of a tablet, from non-destructive and contactless terahertz measurements.  So 79 
far, we have established correlation between the effective THz refractive index and porosity 80 
[21], surface roughness [21], lumped structural parameter [20] DQG <RXQJ¶V PRGXOXV [8]. 81 
Here, we suggest a new optical compressibility parameter and compare it with the measured 82 
bulk modulus of tablets.  83 
Theory 84 
The data analysis in WKLVVWXG\LVEDVHGRQWKHPHDVXUHPHQWRIWLPHGHOD\ǻt) of a terahertz 85 
pulse. The time delay is caused by the more optically dense tablet compared to the undisturbed 86 
propagation of the pulse through nitrogen gas, which is typically used as a reference medium 87 
in laboratory terahertz measurements. Hence, we assume the validity of the following equation 88 ሺ݊ୣ୤୤ െ  ?ሻܪ ൌ ܿȟݐ                                                            (1) 89 
where neff is the effective refractive index of the tablet, H is the height of the round flat-faced 90 
tablet, corresponding in direction to the normal of incidence, and c is the velocity of light in 91 
vacuum. The refractive index of nitrogen is assumed to be equal to unity. 92 
In the derivation of the structural parameter S of a porous pharmaceutical tablet we exploited 93 
the concept of effective permittivity of the tablet and Wiener bounds that define the boundary 94 
range for the effective permittivity in the absence of scattering of the terahertz waves. Aspnes 95 
[22] provides a nice description of Wiener bounds for composite materials by considering two 96 
limiting cases, namely no screening and maximum screening of microstructures in the direction 97 
of the external electric field. This means that, for example, a needle ±shaped particle orientated 98 
parallel to the external electric field (in our case direction of propagation of the THz pulse) 99 
would develop little screening, whereas a disc-shaped particle of the same volume would yield 100 
strong screening. The effective permittivity of a porous pharmaceutical tablet can be assumed 101 
to be constructed from parallel and series connections of the internal solid structures as follows 102 
[20]:  103 ߝୣ୤୤ ൌ ଵభష౏಍౑ ା ౏಍ై                                                                  (2) 104 
where ߝ୙ߝ୐ are the upper and lower Wiener bounds of the permittivity, respectively, and 105 
S is the structural parameter. S is a measure of that fractional part of the randomly distributed 106 
structures in a porous medium that can be lumped together in parallel and in series coordination, 107 
respectively. Since the true value of the effective permittivity of the tablet is always confined 108 
between the upper and lower values of the effective permittivity, the structural parameter S is 109 
a number that ranges from zero (all constituents in parallel) to one (all constituents in series). 110 
The definition of S holds equally for multiphase systems. In our study, we will only deal with 111 
a three-phase system, air and two solid phases, respectively. Eq. (2) was originally defined for 112 
effective heat conductivity [23] of porous media, such as coated paper products, but for the 113 
sake of analogy we have modified the concept for this analogous case, namely to represent the 114 
effective permittivity of porous media.  115 
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In the case of a three-phase system, such as air (or nitrogen gas), micro-crystalline cellulose 116 
(MCC) and active pharmaceutical ingredients (API) in this study, the equations for the upper 117 
and lower Wiener bounds of the effective refractive index are as follows: 118 
   ݊୙ଶ ൌ ୟ݂୧୰ ൅ ୑݂େେ݊୑େେଶ ൅ ୅݂୔୍݊୅୔୍ଶ                                                       (3)       119 
 120 
and                                                                   121 
   
ଵ௡మై ൌ ୟ݂୧୰ ൅ ௙౉ిి௡౉ిిమ ൅ ௙ఽౌ౅௡ఽౌ౅మ                                                                        (4) 122 
where fair, fMCC and fAPI are the volume fractions of air (i.e. the pores constituting the tablet 123 
porosity), MCC and API, respectively. The symbols nMCC and nAPI denote the intrinsic 124 
refractive indices of MCC and API. If we apply the well-known relation from optics for the 125 
real relative permittivity and the refractive index of a non-absorbing insulating medium, 126 
namely, ݊ ൌ  ?ߝ, we get from Eqs. (2)-(4) the expression 127 ܵ ൌ ଵ௡౑మ ି௡మై ሾ௡౑మ ௡ಽమ௡౛౜౜మ െ ݊୐ଶሿ                                                                    (5) 128 
In the pharmaceutical industry, the compressibility of pharmaceutical tablet formulations is an 129 
important factor which determines the required applied force on the composition of powder 130 
mixture to turn it into a structurally stable porous tablet. It greatly affects a range of tablet 131 
properties such as disintegration, dissolution, structural integrity, bioavailability and 132 
absorption as well as the mechanical properties, such as hardness and friability. The 133 
compressibility is defined as a mechanical property, which describes the relationship between 134 
the resulting compact density or strength (hardness / friability) and the compaction pressure 135 
[24].  136 
:HSURSRVHDQ³RSWLFDOFRPSUHVVLELOLW\´SDUDPHWHUWRHVWLPDWHWKHPHFKDQLFDOFRPSUHVVLELOLW\137 
of an excipient or complex formulation based on a simple analysis of the transmitted terahertz 138 
pulse. This ³RSWLFDOFRPSUHVVLELOLW\´is defined by using Eq. (1) as an optical state equation in 139 
analogy to the equation of state of a medium in thermodynamics. For the sake of clarity, we 140 
first consider the simple thermodynamic equation of state of an ideal gas, which is defined with 141 
the aid of the pressure (p), volume (V), absolute temperature (T), the number of gas molecules 142 
ȣDQGWKHJDVFRQVWDQWR) as S9 ȣ57. The optical state equation, namely Eq. (1), resembles 143 
the mathematical form of the thermodynamic state equation of an ideal gas, but obviously has 144 
different variables. The compressibility ȕ, of an ideal gas is defined using the concept of a 145 
partial derivative as follows: 146 ߚ ൌ െ ଵ௏ ቀడ௏డ௣ቁ் ൌ ଵ௣                                                                (6) 147 
The unit of this compressibility is Pa-1. A definition similar to Eq. (6) can be exploited also for 148 
the compressibility of liquids and solids in the field of thermodynamics, but usually the state 149 
equation is more complicated than that of an ideal gas. The interpretation of Eq. (6) states that 150 
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the higher the pressure, the lower is the value of the compressibility. In an analogous manner 151 
to Eq. (6), we define with the aid of Eq. (1) the optical compressibility parameter as 152 ߚ்ு௭ ൌ െ ଵு ቀ డுడ௡౛౜౜ቁ୼௧ ൌ ଵ௡౛౜౜ିଵ                                                       (7) 153 
The dimensionless optical compressibility defined in this way shows inverse dependence of 154 
the compressibility on the effective refractive index, which in turn is linearly correlated to the 155 
density/porosity of the tablet. The interpretation of Eq. (7) is that the denser the medium (i.e. 156 
higher compaction pressure) the higher the effective refractive index, since the density of a 157 
medium is correlating with the refractive index of the medium, and, hence, the lower the optical 158 
compressibility parameter. 159 
Next, we wish to have a more detailed picture regarding the behaviour of the optical 160 
compressibility parameter defined in Eq. (7). For this purpose, we consider an estimate for the 161 
explicit dependence of the optical compressibility on porosity, intrinsic refractive index of the 162 
excipient and the API, and also API mass fraction. An expression for the linear two-variable 163 
(fair, x) approximate effective refractive index of the tablet training sets of this study was given 164 
in [25] as follows: 165 ݊ୣ୤୤ ൌ ݊୑େେ െ ሺ݊୑େେ െ  ?ሻ ୟ݂୧୰ െ ሺ݊୑େେ െ ݊୅୔୍ሻݔ   ,  (8) 166 
  167 
where nMCC and nAPI are the intrinsic refractive indices of MCC and Indomethacin, fair is the 168 
porosity of the tablet, and x is the dimensionless mass fraction (different from fAPI) of the API. 169 
By substituting Eq. (8) into Eq. (7), the optical compressibility can be re-expressed as,  170 ߚ୘ୌ୸ ൌ ଵሺ௡౉ిిିଵሻሺଵି௙౗౟౨ሻିሺ௡౉ిిି௡ఽౌ౅ሻ௫    (9)                                    171 
Since nMCC and nAPI are constants, it is evident from Eq. (9) that ߚ୘ୌ୸ is inversely dependent 172 
(hyperbolic dependence) on the porosity fair or mass fraction x only when one of them is 173 
constant. In a general case, both porosity and the dimensionless mass fraction are considered 174 
to vary. 175 
The optical compressibility ȕTHz depends on S via Eq. (5). If we compare Eqs. (6) and (7), the 176 
message is pretty much similar. The thermodynamic compressibility ȕ becomes less as the 177 
pressure increases. In the case of increasing compression pressure in the tableting process the 178 
porosity of the tablet is decreasing and the effective refractive index is increasing, thus resulting 179 
in the decrease of ȕTHz. The optical compressibility parameter ȕTHz and its connection to the S 180 
structure parameter was studied for the training set of pharmaceutical tablets, and the results 181 
obtained will be shown below. 182 
 183 
Materials and methods 184 
Two sets of round flat-faced pharmaceutical tablets were compressed from the defined 185 
mixtures of pharmaceutical excipient MCC (Avicel PH101, FMC BioPolymer, Philadelphia, 186 
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USA) and API Indomethacin (Hangzhou Dayangchem Co. Ltd., Hangzhou, China). The widely 187 
used MCC is a typical hydrophilic excipient [21], the nominal particle size and true density of 188 
the particulate AviceO3+DUHȝPDQGJ cm-3, respectively. The true density of the 189 
crystalline gamma polymorph of Indomethacin used in this study is 1.37 g cm-3. Two training 190 
sets of flat-faced tablets of constant diameter 13 mm were compacted using a compaction 191 
simulator (PuuMan, Kuopio, Finland). More details on the sample preparation of the tablets 192 
were described previously [26-28]. In Tables 1 and 2, various properties of the training tablet 193 
sets are presented. In tablet Set 1, porosity and API mass fractions were kept constant at ca. 36 194 
% and 10 wt%, respectively, whereas both were varied for the case of the tablet Set 2. For both 195 
tablet sets, five tablets were compressed for each sample number and the given values in Tables 196 
1 and 2 are the average values of 5 tablets belonging to a given tablet number. For each sample, 197 
statistical errors in the calculations made for the nominal porosities are as follows: diameter ± 198 
0.008 mm, height ± 0.005 mm (standard deviation of the sample mean), weight ± 0.01 mg 199 
(readability and sensitivity of the scale), effective refractive index ±0.002 (by assuming a 200 
temporal resolution of 0.02 ps) and porosity ± 0.2 % (calculated using the error propagation 201 
law).  202 
Here we report on two case studies related to the lumped structural S parameter and the optical 203 
compressibility as follows: Case 1; fixed porosity and fixed API mass fraction but variable 204 
height, and Case 2; varied porosity, API mass fraction and height. To calculate the S parameter, 205 
presented in Tables 1 and 2, we have to utilise Eqs. (1) - (5). In order to solve Eqs. (3) and (4), 206 
we have to know the zero porosity refractive indices of nMCC and nAPI, namely, nMCC =1.86 and 207 
nAPI =1.73. The latter value of zero porosity estimate of the refractive index of nAPI is a better 208 
estimate than the one given in [25]. The zero porosity estimates of the refractive index of MCC 209 
and API were obtained by the linear extrapolation technique method as used in [20, 25, 28].  210 
The density of the samples was calculated from the average dimensions and the average 211 
measured weight of the tablet. The tablet porosity was calculated by forming a ratio between 212 
the tablet density and the true density of MCC and Indomethacin, and the S parameter was 213 
calculated by using the equations given in the theory section. In Table 1, we have numbered 214 
the samples according to the order of the increase of the tablet height, not the order of increase 215 
of the effective refractive index. 216 
 217 
 218 
 219 
 220 
 221 
 222 
 223 
 224 
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Table 1:   Data of tablet Set 1. The mean values of the diameter d, height H, weight W, porosity 225 
fair, effective refractive index neff, API mass fraction wt% (x) and calculated S parameter for 226 
four samples are shown. Since the porosity for all of the tablet samples is known, it is possible 227 
to calculate the volume fractions of MCC and API, as was discussed in [20].  228 
Sample 
number 
(Set 1) 
d 
(mm) 
H 
(mm) 
W 
(mg) 
fair 
(%) 
neff 
 
x 
(wt%) 
S 
1 13.097 2.742 361.47 36 1.529 10 0.220 
2 13.078 3.333 438.73 36 1.533 10 0.206 
3 13.066 3.626 476.45 36 1.537 10 0.194 
4 13.062 3.927 514.70 36 1.535 10 0.198 
 229 
Table 2: Data of tablet Set 2. The values of the diameter d, height H, weight W, porosity fair, 230 
effective refractive index neff, API mass fraction wt% (x) and calculated S parameter for five 231 
pharmaceutical tablets are shown.  232 
Sample 
number 
(Set 2) 
d  
(mm) 
H  
(mm) 
W  
(mg) 
fair  
(%) 
neff x 
(wt%) 
S 
1 13.076 3.955 404.02 50 1.405 11.00 0.271 
2 13.075 3.642 403.64 46 1.441 10.50 0.253 
3 13.094 3.273 405.67 40 1.498 10.00 0.219 
4 13.093 2.971 404.23 34 1.551 9.50 0.201 
5 13.081 2.734 406.20 28 1.602 9.00 0.194 
 233 
Skeletal bulk modulus determination 234 
Mercury intrusion measurements were conducted using an Autopore V mercury porosimeter 235 
(Micromeritics Instrument Corporation, Norcross, GA, U.S.A.). The maximum applied 236 
pressure of mercury is 414 MPa, equivalent to a Laplace throat diameter of 4 nm. The 237 
equilibration time at each of the increasing applied pressures of mercury is set to 20 s. The 238 
tablets are measured as supplied.  239 
By observing the behaviour under intrusion and extrusion at the highest pressures it is possible 240 
to ascertain whether the sample displays the typical pore retention hysteresis or whether 241 
mercury is extruded initially at equal volume to that during intrusion as a function of pressure. 242 
If the latter occurs, then it is possible to conclude that the skeletal material is being elastically 243 
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compressed, and the gradient of the elastic response to pressure provides a measure of the 244 
elastic bulk modulus of the skeletal material, i.e. the material bulk modulus of the pore wall 245 
when compressed equally from all directions. If the extrusion, however, exceeds the intrusion 246 
then the skeletal material is partially undergoing strong plastic deformation. The plastic 247 
deformation, however, is generally impossible to quantify as it is convoluted with the usual 248 
mercury retention hysteresis due to necking and filament snapping, and ink bottle behaviour. 249 
Thus, correcting for the elastic behaviour in the data can be included in the overall data 250 
correction during the mercury intrusion comprising the more commonly known effects of 251 
compression of mercury and expansion of the penetrometer [1]. This is performed conveniently 252 
using the software Pore-Comp (a software program developed by and obtainable from the 253 
Environmental and Fluids Modelling Group, University of Plymouth, U.K.), in which the 254 
following equation is applied: 255 
ÕÕÖ
Ô
ÄÄÅ
Ã
ÙÚ
×ÈÉ
Ç //H//ÙÚ
×ÈÉ
Ç ÕÖ
ÔÄÅ
Ã --/?
ss
1
11
bulk10
1
bulkblankobsint
)(
exp1)1(
1820
1log)(175.0
M
PP
V
P
VVVV f
      (10) 256 
where Vint is the volume of intrusion into the sample, Vobs the intruded mercury volume reading, 257 
fVblank the change in the blank run volume reading, V1bulk  the sample bulk volume at 258 
atmospheric pressure, P the applied pressure, H1 the porosity at atmospheric pressure, P1 the 259 
atmospheric pressure and Mss the bulk modulus of the solid sample [29]. 260 
Results and discussion  261 
The values for the optical compressibility parameter, ȕTHz, for the case of Set 1 are shown in 262 
Fig. 1 as a function of S. The porosity and API mass fraction were kept constant and only the 263 
height of the tablets was increased in this Set 1, which causes an increase in the volume of the 264 
tablet. The increase of the volume can be a probable reason for differences in arrangement of 265 
the particles in the direction of the THz pulse propagation, and hence different values of the 266 
lumped structural parameter S. From Table 1 it is evident that the refractive index of the tablets 267 
vary only slightly, whereas much stronger variations can be observed for their structural 268 
parameter S, sensitive to the series-parallel arrangement of constituents in the tablets.  269 
Assuming that all the tablets of Set 1 have the same porosity and API wt%, the conclusion can 270 
be drawn that a different share of series and parallel arrangement of the skeleton structure of 271 
the tablets contributes to slightly different values of the effective refractive index, and that this 272 
is manifested by a rather big change in the value of S. Therefore, S has a descriptor role 273 
regarding also the compressibility of a tablet. Actually, the different heights of the nominally 274 
similar tablets of Set 1 generate essentially different shares of series and parallel structures and, 275 
hence, different values of S. In other words, the packing of API and MCC is different according 276 
to the different tablet heights, and thus, compression. 277 
For the samples in the case of Set 2 we repeated the same analysis procedure as above. Note 278 
that in this case the samples follow a different numbering rule, to the extent that when the tablet 279 
height is decreasing (the volume of the tablet becomes smaller) the effective refractive index 280 
is increasing, as shown in Table 2. In Fig. 2 we plot the structural parameter as a function of 281 
the porosity for Set 2. Here, dependence of the structural parameter S on the porosity suggests 282 
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a nonlinear relationship, which can be mathematically deduced from Eqs. (3) - (5). The range 283 
of variation of S in this case of Set 2 is ca. 0.194 - 0.271, which is much wider than for the case 284 
of Set 1, ca. 0.198 - 0.220. In the case of Set 2, porosity and API are both subject to being 285 
varied. A wider range of porosity change suggests also a wider range of the magnitude of the 286 
structural parameter S.  287 
The optical compressibility parameter ȕTHz as a function of S for tablet Set 2 is shown in Fig. 288 
3. The optical compressibility ȕTHz is increasing with increasing S. The optical compressibility 289 
range of Set 2 is ca 1.66 - 2.47, which is wider than that of Set 1 ca. 1.86 -1.89. Since both the 290 
porosity and the API mass fraction have been changing in the situation of Set 2, it is necessarily 291 
more complex than in the case of Set 1.  292 
Besides the correlation of ȕTHz with the parameter S we also studied the explicit dependence of 293 
ȕTHz on fair and x (shown in Figs. 4 and 5). Fig. 4 suggests a nonlinear, hyperbolic dependence 294 
of ȕTHz on fair. This is consistent with the estimate given in Eq. (9), namely a hyperbolic 295 
dependence of ȕTHz on fair. The data of Fig. 5 show apparently a weaker nonlinearity in respect 296 
to the dependence on x. However, if the mass fraction x would have a wider scale of variation, 297 
hyperbolic dependence of ȕTHz on x would also be expected.  298 
Fig 6 shows the calculated optical compressibility parameter as a function of the measured 299 
mechanical parameter, namely skeletal bulk modulus. It is obvious that there is a correlation 300 
between the optical compressibility and the skeletal bulk modulus. The change of the optical 301 
compressibility is relatively strong as a function of the skeletal bulk modulus if we compare 302 
the samples 3-5 of this set 2, which present low porosity tablets with the lowest API loadings 303 
amongst the present samples. 304 
The skeletal bulk modulus of the sample number 1 of Set 2 (Table 2) has the highest value and 305 
so the least compressible skeletal solid material of the five samples. This sample has the highest 306 
API loading, and so the ratio of API to compressible excipient is the highest. Sample number 307 
5 of Set 2 (Table 2) in turn has the most compressible skeletal material corresponding with the 308 
lowest API loading. The API, therefore, has a high material bulk modulus, and in ratio with the 309 
more compressible excipient determines the observed compressibility of the tablet structure. 310 
Conclusions 311 
Compressibility of a pharmaceutical tablet is an important tablet property. The problem of 312 
measuring compressibility of a tablet is challenging because one needs to detect the change in 313 
volume of a tablet as a function of the compression pressure. This means, typically, that special 314 
measurement arrangements have to be realised under well-controlled laboratory conditions. 315 
Our idea outlined in this paper is to retrieve information on compressibility and, hence, 316 
mechanical properties of a tablet using a non-destructive method based on the THz pulse delay 317 
detection. In this article, we have introduced the concept of optical compressibility of 318 
pharmaceutical tablets.  319 
The optical compressibility was studied for two training tablet sets. A theoretical model that 320 
gives explicit dependence of the optical compressibility of porosity and API mass fraction was 321 
given. The tablets of two differently compressed sets consisted of one excipient, MCC, and one 322 
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API, Indomethacin. For the purpose of describing their compressibility, we derive the concept 323 
of optical compressibility based on the effective refractive index of a tablet. The difference 324 
between the conventional and optical compressibility is that in the latter case there is, in 325 
principle, no longer a need to evaluate physical compressibility by detection of any pressure-326 
induced volume change of the tablet. However, there is a valuable subtlety arising from the 327 
change in packing structure as a function of unidirectional compression. This is seen in a 328 
change of the parallel to series coordination of the skeletal material as monitored by the lumped 329 
parameter structure factor S. Thus, it is possible to derive a compressibility using the optical 330 
approach, and that this optical compressibility is unique to the excipient-API formulation ratio 331 
in that the compression of the tablet leads to a change in effective refractive index together 332 
with a unique packing change. Thus, the combination of neff and S as a function of compressive 333 
force provides a quality control tool for both tablet compression and formulation consistency. 334 
The transmitted terahertz signal, therefore, gives volumetric and structural information on the 335 
tablet as it stands without using any external disturbance. In other words, the optical 336 
compressibility is an intrinsic property of each tablet and its formulation.  337 
Relatively regular behaviour of the optical compressibility as a function of the structural 338 
parameter, S, porosity fair, and API mass fraction x, was obtained for both tablet Sets 1 and 2. 339 
Using the data of skeletal bulk modulus of Set 2 we found a correlation between the optical 340 
compressibility and bulk modulus. The bulk modulus relates only to the direct compressibility 341 
of the material itself making up the skeleton but not that of the skeleton structure.    342 
The study of the structural parameter, as well as the optical compressibility provides a more 343 
comprehensive picture of the properties of a pharmaceutical tablet, and in principle can be used 344 
to understand better the mechanical SURSHUWLHVVXFKDVVWUDLQ<RXQJ¶VPRGXOXV3RLVVRQ¶Vratio 345 
etc. of a tablet. 346 
Finally, we wish to remark that both the lumped structural parameter as well as the optical 347 
compressibility are suggested to be proportional to the surface roughness of a tablet [21]. It 348 
was demonstrated previously that the effective refractive index of tablets is proportional to the 349 
measured average surface roughness. This observation may open new ways to predict various 350 
properties of tablets by terahertz measurements in reflection setting, i.e. reflection of the THz 351 
pulse. Such a concept would be particularly beneficial when the API or excipient strongly 352 
absorbs THz radiation, rendering transmission measurements unfeasible. 353 
 354 
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Figure captions   
Fig. 1: Optical compressibility ȕTHz as a function of structural parameter S for Set 1. 
Fig. 2: Structural parameter S as a function of porosity fair for Set 2. 
Fig. 3: Optical compressibility ȕTHz as a function of structural parameter S for Set 2 
Fig. 4: Optical compressibility ȕTHz as a function of porosity fair for Set 2. 
Fig. 5: Optical compressibility ȕTHz as a function of mass fraction x for Set 2. 
Fig. 6: Optical compressibility ȕTHz as a function of Bulk modulus Mss for Set 2. 
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